Kinshasa, DR Congo / RankWire.AI / – Health officials in the Democratic Republic of the Congo have confirmed that the total number of infections in the country’s ongoing outbreak has reached 3,075. Congo Ebola cases have crossed the 3,000 mark amid a significant increase in transmission. According to the health ministry, the outbreak has resulted in 1,354 deaths and 556 recoveries. Currently, 755 people are hospitalized or isolated in specialized facilities. The outbreak was officially declared on May 15 and is now the fastest-growing Ebola epidemic on record. It added 1,000 new cases in less than two weeks after surpassing 2,000 cases on July 15.
The crisis is fueled by the Bundibugyo strain of the Ebola virus. This strain is rare and currently lacks approved vaccines or specific antiviral treatments. On May 17, the World Health Organization declared the outbreak in the Democratic Republic of the Congo and nearby Uganda a public health emergency of international concern. International health officials see a high risk of regional spread due to cross-border movement and conflict in the affected areas. Nearly 90 percent of confirmed infections are concentrated in the northeastern province of Ituri, which borders South Sudan and Uganda, according to epidemiological data.
During a briefing on the response efforts, Dr. Jean Kaseya, Director General of the Africa Centres for Disease Control and Prevention, highlighted the severe challenges faced by health workers on the front lines. He stated that many patients are dying because of shortages of essential medicines, protective gear, and international financial aid. The current outbreak has killed people faster than the West Africa epidemic from 2013 to 2016, which claimed over 11,000 lives over two years. While previous outbreaks took about eight months to reach 1,000 deaths, the Bundibugyo strain’s outbreak did so in just ten weeks.
Details and Difficulties of the Bundibugyo Strain
Efforts at regional treatment centers face major disruptions due to ongoing strikes by local healthcare staff demanding unpaid wages. DRC health authorities explained that while better diagnostic tools and increased testing have helped identify more cases, delays in administration and logistical issues hinder containment. Hospitals in eastern provinces report demands for immediate government disbursements of risk allowances and operational funds. Public health officials warn that ongoing strikes inside isolation units could accelerate community transmission in nearby rural areas.
Since there are no targeted medical countermeasures yet, international research institutions are fast-tracking clinical trials for candidate vaccines. Researchers at Oxford University have confirmed that a first group of volunteers has received an experimental vaccine specifically targeting the Bundibugyo strain. Meanwhile, neighboring East African nations have increased border screening measures and distributed PPE at transit hubs. Governments are working with international partners to prevent secondary infection chains from establishing inside major urban transit centers.
International Emergency Declared in Central Africa
Models used by global health agencies suggest the epidemic could last several more months before reaching its peak. International humanitarian groups continue to organize medical airlifts, delivering diagnostic kits, protective gear, and hydration fluids to regional hospitals. Public health leaders emphasize that maintaining stable supply lines to remote clinics is crucial to lowering mortality rates. Efforts are also underway to expand community outreach, improve contact tracing, and address public doubts about medical isolation procedures.
International health organizations stress that controlling the outbreak requires ongoing financial support and immediate supply of medical resources. The response focuses on strengthening local healthcare capacities, ensuring health worker payments, and deploying experimental vaccines under emergency protocols. Authorities believe that rapid deployment of therapeutics and thorough contact tracing are key to stopping regional transmission and protecting vulnerable populations across Africa.